Mechanisms involved in enhancement of the expression and function of aggrecanases by hyaluronan oligosaccharides

Arthritis and Rheumatism

Volumn 64, Issue 1, 2012, Pages 187-197

  Ariyoshi, Wataru ^a,c   Takahashi, Nobunori ^b   Hida, Daisuke ^a   Knudson, Cheryl B ^a   Knudson, Warren ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^c KYUSHU DENTAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECANASE 1; AGGRECANASE 2; HERMES ANTIGEN; HYALURONAN OLIGOSACCHARIDE; HYALURONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE 17; OLIGOSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARTILAGE CELL; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; IMMUNOPRECIPITATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AGGRECANS; ANIMALS; ANTIGENS, CD44; CARTILAGE, ARTICULAR; CATTLE; CELLS, CULTURED; CHONDROCYTES; CHROMONES; COLLAGEN TYPE II; DRUG THERAPY, COMBINATION; ENDOPEPTIDASES; FLAVONOIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUCURONOSYLTRANSFERASE; HYALURONIC ACID; IMIDAZOLES; LACTONES; MORPHOLINES; OLIGOSACCHARIDES; PYRIDINES; SESQUITERPENES, EUDESMANE; SIGNAL TRANSDUCTION; VISCOSUPPLEMENTS;

EID: 84855282450     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.33329     Document Type: Article

References (41)

1. Toole BP,. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 2004; 4: 528-39. (Pubitemid 38868622)
2. Hardingham TE, Fosang AJ,. Proteoglycans: many forms and many functions. FASEB J 1992; 6: 861-70.
3. Knudson CB, Knudson W,. Hyaluronan and CD44: modulators of chondrocyte metabolism. Clin Orthop Relat Res 2004; 427 SUPPL.: S152-62. (Pubitemid 39362816)
4. Knudson W, Aguiar DJ, Hua Q, Knudson CB,. CD44-anchored hyaluronan-rich pericellular matrices: an ultrastructural and biochemical analysis. Exp Cell Res 1996; 228: 216-28. (Pubitemid 26384652)
5. Evanko SP, Angello JC, Wight TN,. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999; 19: 1004-13. (Pubitemid 29177349)
6. Underhill CB, Toole BP,. Binding of hyaluronate to the surface of cultured cells. J Cell Biol 1979; 82: 475-84. (Pubitemid 9241111)
7. Knudson W, Bartnik E, Knudson CB,. Assembly of pericellular matrices by COS-7 cells transfected with CD44 homing receptor genes. Proc Natl Acad Sci U S A 1993; 90: 4003-07. (Pubitemid 23134154)
8. Lesley J, Hascall VC, Tammi M, Hyman R,. Hyaluronan binding by cell surface CD44. J Biol Chem 2000; 275: 26967-75.
9. Knudson W, Casey B, Nishida Y, Eger W, Kuettner KE, Knudson CB,. Hyaluronan oligosaccharides perturb cartilage matrix homeostasis and induce chondrogenic chondrolysis. Arthritis Rheum 2000; 43: 1165-74. (Pubitemid 30368196)
10. Ohno S, Im HJ, Knudson CB, Knudson W,. Hyaluronan oligosaccharide-induced activation of transcription factors in bovine articular chondrocytes. Arthritis Rheum 2005; 52: 800-9. (Pubitemid 40365102)
11. Iacob S, Knudson CB,. Hyaluronan fragments activate nitric oxide synthase and the production of nitric oxide by articular chondrocytes. Int J Biochem Cell Biol 2006; 38: 123-33. (Pubitemid 41540723)
12. Ohno S, Im HJ, Knudson CB, Knudson W,. Hyaluronan oligosaccharides induce matrix metalloproteinase 13 via transcriptional activation of NFκB and p38 MAP kinase in articular chondrocytes. J Biol Chem 2006; 281: 17952-60. (Pubitemid 44035594)
13. Schmitz I, Ariyoshi W, Takahashi N, Knudson CB, Knudson W,. Hyaluronan oligosaccharide treatment of chondrocytes stimulates expression of both HAS-2 and MMP-3, but by different signaling pathways. Osteoarthritis Cartilage 2010; 18: 447-54.
14. Ponta H, Sherman L, Herrlich P,. CD44: from adhesion molecules to signaling regulators. Nature Rev Mol Cell Biol 2003; 4: 33-45. (Pubitemid 36077255)
15. Girish KS, Kemparaju K, Nagaraju S, Vishwanath BS,. Hyaluronidase inhibitors: a biological and therapeutic perspective. Curr Med Chem 2009; 16: 2261-88.
16. Goldring MB, Goldring SR,. Osteoarthritis. J Cell Physiol 2007; 213: 626-34. (Pubitemid 350058254)
17. Arner EC, Pratta MA, Trzaskos JM, Decicco CP, Tortorella MD,. Generation and characterization of aggrecanase: a soluble, cartilage-derived aggrecan-degrading activity. J Biol Chem 1999; 274: 6594-601. (Pubitemid 29111077)
18. Apte SS,. A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms. J Biol Chem 2009; 284: 31493-7.
19. Song RH, Tortorella MD, Malfait AM, Alston JT, Yang Z, Arner EC, et al. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum 2007; 56: 575-85.
20. Naito S, Shiomi T, Okada A, Kimura T, Chijiiwa M, Fujita Y, et al. Expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic cartilage. Pathol Int 2007; 57: 703-11. (Pubitemid 47537631)
21. Gao G, Plaas A, Thompson VP, Jin S, Zuo F, Sandy JD,. ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosyl phosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfate on syndecan-1. J Biol Chem 2004; 279: 10042-51. (Pubitemid 38372607)
22. Ilic MZ, Handley CJ, Robinson HC, Mok MT,. Mechanism of catabolism of aggrecan by articular cartilage. Arch Biochem Biophys 1992; 294: 115-22.
23. Nishida Y, Knudson CB, Kuettner KE, Knudson W,. Osteogenic protein-1 promotes the synthesis and retention of extracellular matrix within bovine articular cartilage and chondrocyte cultures. Osteoarthritis Cartilage 2000; 8: 127-36. (Pubitemid 30159152)
24. Rasmussen TB, Uttenthal A, de Stricker K, Belak S, Storgaard T,. Development of a novel quantitative real-time RT-PCR assay for the simultaneous detection of all serotypes of foot-and-mouth disease virus. Arch Virol 2003; 148: 2005-21. (Pubitemid 37284019)
25. Pfaffl MW,. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: e45.
26. Pockert AJ, Richardson SM, Le Maitre CL, Lyon M, Deakin JA, Buttle DJ, et al. Modified expression of the ADAMTS enzymes and tissue inhibitor of metalloproteinases 3 during human intervertebral disc degeneration. Arthritis Rheum 2009; 60: 482-91.
27. Ariyoshi W, Knudson CB, Luo N, Fosang AJ, Knudson W,. Internalization of aggrecan G1 domain neoepitope ITEGE in chondrocytes requires CD44. J Biol Chem 2010; 285: 36216-24.
28. Itoh Y, Kajita M, Kinoh H, Mori H, Okada A, Seiki M,. Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol- anchored proteinase. J Biol Chem 1999; 274: 34260-6. (Pubitemid 129511766)
29. Lemke AK, Sandy JD, Voigt H, Dreier R, Lee JH, Grodzinsky AJ, et al. Interleukin-1α treatment of meniscal explants stimulates the production and release of aggrecanase-generated, GAG-substituted aggrecan products and also the release of pre-formed, aggrecanase-generated G1 and m-calpain-generated G1-G2. Cell Tissue Res 2010; 340: 179-88.
30. Ward JA, Huang L, Guo H, Ghatak S, Toole BP,. Perturbation of hyaluronan interactions inhibits malignant properties of glioma cells. Am J Pathol 2003; 162: 1403-9. (Pubitemid 36512822)
31. Ghatak S, Misra S, Toole BP,. Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem 2002; 277: 38013-20. (Pubitemid 35154652)
32. Toole BP,. Hyaluronan-CD44 interactions in cancer: paradoxes and possibilities. Clin Cancer Res 2009; 15: 7462-68.
33. Hosono K, Nishida Y, Knudson W, Knudson CB, Naruse T, Suzuki Y, et al. Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells. Am J Pathol 2007; 171: 274-86. (Pubitemid 47339244)
34. Slomiany MG, Dai L, Tolliver LB, Grass GD, Zeng Y, Toole BP,. Inhibition of functional hyaluronan-CD44 interactions in CD133-positive primary human ovarian carcinoma cells by small hyaluronan oligosaccharides. Clin Cancer Res 2009; 15: 7593-601.
35. Fitzgerald KA, Bowie AG, Skeffington BS, O'Neill LA,. Ras, protein kinase Cζ, and IκB kinases 1 and 2 are downstream effectors of CD44 during the activation of NF-κB by hyaluronic acid fragments in T-24 carcinoma cells. J Immunol 2000; 164: 2053-63. (Pubitemid 30108763)
36. Lyss G, Knorre A, Schmidt TJ, Pahl HL, Merfort I,. The anti-inflammatory sesquiterpene lactone helenalin inhibits the transcription factor NF-κB by directly targeting p65. J Biol Chem 1998; 273: 33508-16. (Pubitemid 29005734)
37. + T cells by multiple mechanisms. Mol Immunol 2009; 46: 2892-901.
38. Chockalingam PS, Varadarajan U, Sheldon R, Fortier E, LaVallie ER, Morris EA, et al. Involvement of protein kinase Cζ in interleukin-1β induction of ADAMTS-4 and type 2 nitric oxide synthase via NF-κB signaling in primary human osteoarthritic chondrocytes. Arthritis Rheum 2007; 56: 4074-83. (Pubitemid 350262335)
39. Chu SC, Marks-Konczalik J, Wu HP, Banks TC, Moss J,. Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: characterization of differences between human and mouse iNOS promoters. Biochem Biophys Res Commun 1998; 248: 871-8. (Pubitemid 28404515)
40. Yatabe T, Mochizuki S, Takizawa M, Chijiiwa M, Okada A, Kimura T, et al. Hyaluronan inhibits expression of ADAMTS-4 (aggrecanase-1) in human osteoarthritic chondrocytes. Ann Rheum Dis 2009; 68: 1051-8.
41. Gao G, Westling J, Thompson VP, Howell TD, Gottschall PE, Sandy JD,. Activation of the proteolytic activity of ADAMTS4 (aggrecanase-1) by C-terminal truncation. J Biol Chem 2002; 277: 11034-41. (Pubitemid 34952861)